Company intelligence / Profile preview

Denver Farma

Munro, Buenos Aires Province, Argentinadenverfarma.com.ar ↗
Ownership
Private
Employees
~260
Development stage
Commercial
01

Overview

Denver Farma is a pharmaceutical company that manufactures a wide range of pharmaceutical forms. In 2017, they became the only company in South America to produce DNA recombinant human insulin.

Modalities
Tabletscapsulespowderscreamsgelsointmentsdressingsaerosol sprayseye dropsinjectablesblister vialsrecombinant human insulin
Industry
Biotech
02

Drug pipeline

2 assets

cyclopentolate (Denver Farma)

Approved

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Denver Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denver Farma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call